Minor tranquillizers for short-term treatment of newly onset symptoms of anxiety and distress : a systematic review with network meta-analysis of randomized trials
© 2023. The Author(s)..
Unspecific symptoms of anxiety and distress are frequently encountered in patients in both general practice and acute psychiatric services. Minor tranquillizers may be a treatment option when non-pharmacological interventions are insufficient or unavailable. We conducted a systematic review with network meta-analysis of the evidence for short-term (1-4 weeks) pharmacological treatment of newly onset symptoms of anxiety and distress. We searched the PsycInfo, MEDLINE, EMBASE and Cochrane Library databases and extracted data following a predefined hierarchy of outcomes. We assessed risk of bias using the Cochrane Risk of Bias tool and the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation framework (GRADE). We included 34 randomized trials comprising a total of 7044 patients with adjustment disorders or anxiety spectrum disorders. The network meta-analysis showed that regarding the critical outcome symptoms of anxiety within 1-4 weeks benzodiazepines (SMD - 0.58, 95% CI - 0.77 to - 0.40), quetiapine (SMD - 0.51, 95% CI - 0.90 to - 0.13) and pregabalin (SMD - 0.58, 95% CI - 0.87 to - 0.28) all performed better than placebo with no statistically significant difference between the drugs. Data on other important outcomes were inconsistently reported. Adverse effects varied, but overall, it was uncertain whether adverse effects differed between interventions. The evidence regarding the risk of dependence was uncertain, but dependence may be a concern in susceptible individuals even with short-term treatment. Overall, the certainty of the evidence according to GRADE was rated as low to very low across outcomes. Despite the limitations in the evidence, the results of this review can inform treatment guidelines, supporting clinicians in the choice of minor tranquillizer in this prevalent and help-seeking, clinically heterogeneous population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:274 |
|---|---|
| Enthalten in: |
European archives of psychiatry and clinical neuroscience - 274(2024), 3 vom: 01. Apr., Seite 475-486 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Munkholm, Klaus [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Anxiety Agents |
|---|
| Anmerkungen: |
Date Completed 05.04.2024 Date Revised 07.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00406-023-01680-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361226225 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361226225 | ||
| 003 | DE-627 | ||
| 005 | 20240407232235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00406-023-01680-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1368.xml |
| 035 | |a (DE-627)NLM361226225 | ||
| 035 | |a (NLM)37624378 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Munkholm, Klaus |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Minor tranquillizers for short-term treatment of newly onset symptoms of anxiety and distress |b a systematic review with network meta-analysis of randomized trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.04.2024 | ||
| 500 | |a Date Revised 07.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a Unspecific symptoms of anxiety and distress are frequently encountered in patients in both general practice and acute psychiatric services. Minor tranquillizers may be a treatment option when non-pharmacological interventions are insufficient or unavailable. We conducted a systematic review with network meta-analysis of the evidence for short-term (1-4 weeks) pharmacological treatment of newly onset symptoms of anxiety and distress. We searched the PsycInfo, MEDLINE, EMBASE and Cochrane Library databases and extracted data following a predefined hierarchy of outcomes. We assessed risk of bias using the Cochrane Risk of Bias tool and the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation framework (GRADE). We included 34 randomized trials comprising a total of 7044 patients with adjustment disorders or anxiety spectrum disorders. The network meta-analysis showed that regarding the critical outcome symptoms of anxiety within 1-4 weeks benzodiazepines (SMD - 0.58, 95% CI - 0.77 to - 0.40), quetiapine (SMD - 0.51, 95% CI - 0.90 to - 0.13) and pregabalin (SMD - 0.58, 95% CI - 0.87 to - 0.28) all performed better than placebo with no statistically significant difference between the drugs. Data on other important outcomes were inconsistently reported. Adverse effects varied, but overall, it was uncertain whether adverse effects differed between interventions. The evidence regarding the risk of dependence was uncertain, but dependence may be a concern in susceptible individuals even with short-term treatment. Overall, the certainty of the evidence according to GRADE was rated as low to very low across outcomes. Despite the limitations in the evidence, the results of this review can inform treatment guidelines, supporting clinicians in the choice of minor tranquillizer in this prevalent and help-seeking, clinically heterogeneous population | ||
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anxiety | |
| 650 | 4 | |a Distress | |
| 650 | 4 | |a Minor tranquilizers | |
| 650 | 4 | |a Network meta-analysis. | |
| 650 | 4 | |a Systematic review | |
| 650 | 7 | |a Anti-Anxiety Agents |2 NLM | |
| 700 | 1 | |a Ussing, Anja |e verfasserin |4 aut | |
| 700 | 1 | |a Brink, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Edemann-Callesen, Henriette |e verfasserin |4 aut | |
| 700 | 1 | |a Canbolat, Sengül Sari |e verfasserin |4 aut | |
| 700 | 1 | |a Christensen, Robin |e verfasserin |4 aut | |
| 700 | 1 | |a Dahl, Kristine Søgaard |e verfasserin |4 aut | |
| 700 | 1 | |a Ebdrup, Bjørn H |e verfasserin |4 aut | |
| 700 | 1 | |a Jensen, Mikkel Erik Juul |e verfasserin |4 aut | |
| 700 | 1 | |a Kierulf-Lassen, Casper |e verfasserin |4 aut | |
| 700 | 1 | |a Madsen, Gitte Krogh |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Sabrina Mai |e verfasserin |4 aut | |
| 700 | 1 | |a Paulsen, Camilla Paludan |e verfasserin |4 aut | |
| 700 | 1 | |a Rohde, Jeanett Friis |e verfasserin |4 aut | |
| 700 | 1 | |a Tarp, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Baandrup, Lone |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European archives of psychiatry and clinical neuroscience |d 1996 |g 274(2024), 3 vom: 01. Apr., Seite 475-486 |w (DE-627)NLM012966681 |x 1433-8491 |7 nnns |
| 773 | 1 | 8 | |g volume:274 |g year:2024 |g number:3 |g day:01 |g month:04 |g pages:475-486 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00406-023-01680-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 274 |j 2024 |e 3 |b 01 |c 04 |h 475-486 | ||